相关实验视频
Updated: May 11, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
针对局部软组织肉瘤的新辅助放射治疗的剂量和分量更新
Siyer Roohani1,2,3, Lisette M Wiltink4, David Kaul5,6
1Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. siyer.roohani@charite.de.
Current treatment options in oncology
|March 13, 2024
概括
软组织瘤 (STS) 的新辅助放射治疗 (RT) 可能会从更短,低分离的疗程中受益. 虽然标准RT是常见的,但较短的治疗方法对特定亚型 (如myxoid liposarcomas和retroperitoneal liposarcomas) 有希望.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 手术瘤学手术瘤学
背景情况:
- 针对局部高度软组织瘤 (STS) 的标准新辅助放射治疗 (RT) 需要5-6周的治疗.
- 作为一种替代方案,正在研究低分化手术前RT,治疗时间较短.
- 对于逆皮质肉瘤来说,RT不是标准的,尽管某些亚型可能会受益.
研究的目的:
- 审查软组织肉瘤新辅助放射治疗的当前情况.
- 讨论低分数RT时间表的潜力.
- 要突出针对特定类型的肉瘤亚型的发现,包括状脂类肉瘤和逆皮质脂类肉瘤.
主要方法:
- 对现有的II期试验和随机化研究 (DOREMY,STRASS,STREXIT) 的审查.
- 分析不同RT分成方案的瘤结果和毒性概况.
- 检查特定软组织肉瘤亚型的证据.
主要成果:
- 状脂类瘤显示出优异的局部控制与较短的手术前RT剂量 (36Gy在3-4周).
- 第二阶段的研究表明,低分化RT可能会达到与传统RT相似的结果.
- 斯特拉斯试验没有发现手术前RT对回皮质肉瘤的整体益处,但对不分化脂肪肉瘤的潜在生存益处.
结论:
- 低分离的手术前RT是一种有前途的方法,用于局部高度STS,特别是myxoid liposarcomas.
- 需要进一步的前性研究来直接比较低分离RT与传统RT.
- 手术前的RT可能为特定的逆皮质脂肪瘤亚型提供生存益处,需要与患者讨论.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

